The authors observed a long-lasting response to uninterrupted vinorelbine treatment in a 72-year-old patient with a stage IIIB unresectable non-small cell carcinoma. The progressive tumor mass reduction was assessed by computed tomographic scans over a 2-year period. In the literature, data of randomized trials confirm that the appeal of single-agent vinorelbine therapy in elderly patients is also good for the patient's quality of life during treatment.
Long-lasting response to vinorelbine in unresectable non-small cell lung carcinoma: A case with concomitant good quality of life / Seminara, P., Francesco, L., Gualdi, G., Donato, V., Caterina, A., Paola, P., Franchi, F.. - In: THE AMERICAN JOURNAL OF THE MEDICAL SCIENCES. - ISSN 0002-9629. - STAMPA. - 316:6(1998), pp. 398-400. [10.1097/00000441-199812000-00008]
Long-lasting response to vinorelbine in unresectable non-small cell lung carcinoma: A case with concomitant good quality of life
SEMINARA, Patrizia;GUALDI, GIANFRANCO;DONATO, Vittorio;FRANCHI, Fabrizio
1998
Abstract
The authors observed a long-lasting response to uninterrupted vinorelbine treatment in a 72-year-old patient with a stage IIIB unresectable non-small cell carcinoma. The progressive tumor mass reduction was assessed by computed tomographic scans over a 2-year period. In the literature, data of randomized trials confirm that the appeal of single-agent vinorelbine therapy in elderly patients is also good for the patient's quality of life during treatment.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
